# A Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HLX3901 in Patients With Advanced SCLC or NEC

> clinical trial · VERIFIED · 2026-07-08

Status: RECRUITING · Sponsor: Shanghai Henlius Biotech · Condition: SCLC

- Company: Shanghai Henlius Biotech
- Sector: SCLC
- Primary source: https://clinicaltrials.gov/study/NCT07416695

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.